ArticleBJR open2026
Predictive value of digital breast tomosynthesis based intratumoral-peritumoral radiomics and clinical features for benign-malignant breast microcalcifications.
Article in BJR open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To investigate the value of clinical and radiomics features in distinguishing benign from malignant breast microcalcifications and develop a noninvasive model to reduce unnecessary biopsies. Methods: This retrospective study analyzed 181 microcalcification lesions from 172 patients. Lesions were divided into training/validation sets (7:3). Manual volumes of interest were delineated on digital breast tomosynthesis images. Radiomics features were extracted from intratumoral and peritumoral regions. Among 9 machine learning classifiers, the optimal performer was selected to develop 3 radiomics models: intratumoral model (RM0), intratumoral and peritumoral 1 mm model (RM1), intratumoral and peritumoral 3 mm model (RM3). Independent clinical risk factors identified by univariate and multivariate logistic regression were integrated with the optimal radiomics model to build a nomogram model (NM). Model performance was evaluated using receiver operating characteristic (ROC) curves, calibration curves, decision curve analysis, and clinical impact curves. Results: RM0 performed best. Independent risk factors included: Breast Imaging Reporting and Data System (BI-RADS) category ( Conclusions: Single clinical features showed potential predictive value for microcalcifications, while the integrated model might not demonstrate adequate discriminative power. Advances in knowledge: This study highlights the need for noninvasive differentiation of microcalcifications and suggests that while individual clinical factors have value, combined modeling requires further optimization.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.